Journals / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 1

Uterine sarcomas: clinical presentation and MRI features

Pages
4–9
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This pictorial review aims to discuss the clinical features of uterine sarcomas, as well as their most common appearances and distinct characteristics in MRI

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for approximately 8% of uterine malignancies.
📊
Key Findings & Data:Due to their distinct clinical and biological behavior, the International Federation of Gynecology and Obstetrics introduced a new staging system for uterine sarcomas in 2009, categorizing uterine carcinosarcoma as a variant of endometrial carcinoma, rather than a pure sarcoma.
💡
Conclusion & Impact:This pictorial review aims to discuss the clinical features of uterine sarcomas, as well as their most common appearances and distinct characteristics in MRI
🔬Design:Review & Systematic Survey
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for approximately 8% of uterine malignancies. They comprise leiomyosarcoma, endometrial stromal sarcoma, undifferentiated endometrial sarcoma, and adenosarcoma. Compared with the more common endometrial carcinomas, uterine sarcomas behave more aggressively and are associated with a poorer prognosis. Due to their distinct clinical and biological behavior, the International Federation of Gynecology and Obstetrics introduced a new staging system for uterine sarcomas in 2009, categorizing uterine carcinosarcoma as a variant of endometrial carcinoma, rather than a pure sarcoma. Magnetic resonance imaging (MRI) has a developing role in the assessment of these malignancies. Features such as tumor localization, irregular or nodular margins, necrosis, rapid growth, intense contrast enhancement, and restriction at diffusion-weighted imaging can suggest the diagnosis and help differentiate from more common leiomyomas and endometrial carcinoma. MRI is therefore extremely useful in preoperative detection and staging and, consequently, in determination of appropriate management. This pictorial review aims to discuss the clinical features of uterine sarcomas, as well as their most common appearances and distinct characteristics in MRI

🔖

Cite This Article

SANTOS, P., CUNHA, T. M. (2015). Uterine sarcomas: clinical presentation and MRI features. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 1, 4–9. https://ajindex.com/articles/213564

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Wu TI, Yen TC, Lai CH. Clinical presenta- tion and diagnosis of uterine sarcoma, in- cluding imaging. Best Pract Res Clin Obstet Gynaecol 2011; 25:681-689. [CrossRef] Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Ra- diology 2013; 266:717-740. [CrossRef] Shaan SH, Jagannathan JP, Krajewski K, O'Regen KN, George S, Ramaiya NH. Uter- ine sarcomas: then and now. AJR Am J Roentgenol 2012; 199:213-223. [CrossRef] Memarzadeh S, Mundt AJ, Berek JS. Uter- ine sarcoma: Classification, clinical man- ifestations, and diagnosis. In: UpToDate, Goff B, Falk SJ, eds. 2012.
  2. Seddon BM, Davda R. Uterine sarcomas - recent progress and future challenges. Eur J Radiol 2011; 78:30-40. [CrossRef] Tse KY, Crawford R, Ngan HYS. Staging of uterine sarcomas. Best Pract Res Clin Obstet Gynaecol 2011; 25:733-749. [CrossRef] FIGO Committee on Gynecologic Oncol- ogy. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009; 106:277. D'Angelo A, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010; 116:131-139. [CrossRef] Namimoto T, Yamashita Y, Awai K, et al. Com- bined use of T2-weighted and diffusion-weight- ed 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2009; 19:2756-2764. [CrossRef] Tamai K, Koyama T, Saga T, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008; 18:723-730. [CrossRef] Rha SE, Byun JY, Jung SE, et al. CT and MRI of Uterine Sarcomas and their mimickers. AJR Am J Roentgenol 2003; 181:1369-1374. [CrossRef] Thomassin-Naggara I, Dechoux S, Bon- neau C, et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 2013; 23:2306-2314. [CrossRef] World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. In Tavassoli FA, Devilee P, Eds. Lyon: IARC Press, 2003.
  3. Lenhard SM, Untch M, Himsl I, et al. The high-grade endometrial sarcoma: a rare entity. Arch Gynecol Obstet 2006; 274:56-59. [CrossRef] Ueda M, Otsuka M, Hatakenaka M, et al. MR imaging findings of uterine endo- metrial stromal sarcoma: differentiation from endometrial carcinoma. Eur Radiol 2001; 11:28-33. [CrossRef] Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009; 10:1188-